The effect of donor distance on post-transplant mortality in the modern era

David Rekhtman1, Sharon Lee1, Amit Iyengar2

  • 1Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.

JTCVS Open
|July 9, 2025
PubMed

Insights

Extended travel for heart transplants does not impact survival. Focus on ischemic time, not distance, for organ procurement policies to improve heart transplant outcomes.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Public Health Policy

Background:

  • The US heart transplant allocation system allows organs to travel beyond 250 miles.
  • The impact of extended travel distances and associated ischemic times on heart transplant outcomes is not well understood.

Purpose of the Study:

  • To examine the relationship between donor-recipient distance and post-transplant mortality.
  • To assess the influence of extended travel on ischemic time and patient survival in heart transplantation.

Main Methods:

  • Analysis of adult patients receiving isolated heart transplants from October 2018 to September 2023 using the United Network for Organ Sharing database.
  • Stratification of patients based on donor distance (≤250 or >250 miles) and analysis of 1-year survival, ischemic time, and mortality using regression and Kaplan-Meier methods.

Main Results:

  • 55% of 5315 heart transplant recipients received organs from donors >250 miles away.
  • Each 100-mile increase in travel distance added 18 minutes to ischemic time.
  • Increased ischemic time predicted mortality, but increased donor distance did not impact 1-year survival.

Conclusions:

  • Donor-recipient travel distance has minimal impact on ischemic time and no significant effect on 1-year post-transplant survival.
  • Ischemic time, rather than arbitrary distance cutoffs, should guide organ procurement policies for heart transplants.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
64
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
524
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
504
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
78